Condensed Consolidated Statements Of Shareholders' Equity - USD ($) $ in Millions	Total	Common Stock [Member]	Accumulated Deficit [Member]	Accumulated Other Comprehensive Loss [Member]
Common stock, balance, beginning of period at Feb. 01, 2020		$ 3,129
Common stock
Issuance of common stock under stock compensation plans		16
Stock-based compensation		45
Common stock, balance, end of period at Oct. 31, 2020	$ 3,190	3,190
Accumulated deficit, balance, beginning of period at Feb. 01, 2020			$ (2,082)
Accumulated deficit
Net earnings (loss)	(723)		(723)
Dividends			(58)
Accumulated deficit, balance, end of period at Oct. 31, 2020	(2,863)		(2,863)
Accumulated other comprehensive loss, balance, beginning of period at Feb. 01, 2020				$ (68)
Accumulated other comprehensive loss
Other comprehensive income (loss)				(7)
Accumulated other comprehensive loss, balance, end of period at Oct. 31, 2020	(75)			(75)
Total shareholders’ equity at Oct. 31, 2020	$ 252
Accumulated other comprehensive loss
Dividends per share	$ 0.37
Common stock, balance, beginning of period at Aug. 01, 2020		3,168
Common stock
Issuance of common stock under stock compensation plans		5
Stock-based compensation		17
Common stock, balance, end of period at Oct. 31, 2020	$ 3,190	3,190
Accumulated deficit, balance, beginning of period at Aug. 01, 2020			(2,916)
Accumulated deficit
Net earnings (loss)	53		53
Dividends			0
Accumulated deficit, balance, end of period at Oct. 31, 2020	(2,863)		(2,863)
Accumulated other comprehensive loss, balance, beginning of period at Aug. 01, 2020				(78)
Accumulated other comprehensive loss
Other comprehensive income (loss)				3
Accumulated other comprehensive loss, balance, end of period at Oct. 31, 2020	(75)			(75)
Total shareholders’ equity at Oct. 31, 2020	$ 252
Accumulated other comprehensive loss
Dividends per share	$ 0
Common stock, balance, beginning of period at Jan. 30, 2021	$ 3,205	3,205
Common stock
Issuance of common stock under stock compensation plans		14
Stock-based compensation		50
Common stock, balance, end of period at Oct. 30, 2021	3,269	3,269
Accumulated deficit, balance, beginning of period at Jan. 30, 2021	(2,830)		(2,830)
Accumulated deficit
Net earnings (loss)	(22)		(22)
Dividends			0
Accumulated deficit, balance, end of period at Oct. 30, 2021	(2,852)		(2,852)
Accumulated other comprehensive loss, balance, beginning of period at Jan. 30, 2021	(70)			(70)
Accumulated other comprehensive loss
Other comprehensive income (loss)				12
Accumulated other comprehensive loss, balance, end of period at Oct. 30, 2021	(58)			(58)
Total shareholders’ equity at Oct. 30, 2021	$ 359
Accumulated other comprehensive loss
Dividends per share	$ 0
Common stock, balance, beginning of period at Jul. 31, 2021		3,245
Common stock
Issuance of common stock under stock compensation plans		7
Stock-based compensation		17
Common stock, balance, end of period at Oct. 30, 2021	$ 3,269	$ 3,269
Accumulated deficit, balance, beginning of period at Jul. 31, 2021			(2,916)
Accumulated deficit
Net earnings (loss)	64		64
Dividends			0
Accumulated deficit, balance, end of period at Oct. 30, 2021	(2,852)		$ (2,852)
Accumulated other comprehensive loss, balance, beginning of period at Jul. 31, 2021				(61)
Accumulated other comprehensive loss
Other comprehensive income (loss)				3
Accumulated other comprehensive loss, balance, end of period at Oct. 30, 2021	(58)			$ (58)
Total shareholders’ equity at Oct. 30, 2021	$ 359
Accumulated other comprehensive loss
Dividends per share	$ 0